Literature DB >> 8164455

Cerebral arterial disturbances in a transient encephalopathy induced by methotrexate.

J Y Follezou1, L Chauveinc, J M Guerin.   

Abstract

The mechanism of the transient encephalopathy induced by high dose systemic administration of methotrexate (HDMTX) is unknown. Metabolic and vascular hypothesis have been formulated but convincing evidence is lacking. We report the first case of vascular disturbances (thinness of cortical arteries on angiography, reversible fall down of cerebral flow and increase of carotid resistance) in a young Algerian patient treated for an osteogenic osteosarcoma. This observation might lead to the exploration by non invasive and easily repeatable techniques of the cerebral vascular dynamic in patients submitted to HDMTX and thus contributed to the elucidation of the mechanism and to the prevention of these neurological side effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8164455     DOI: 10.1007/bf02989667

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  14 in total

1.  Paraplegia following intrathecal methotrexate: report of a case and review of the literature.

Authors:  R G Gagliano; J J Costanzi
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

Review 2.  Paraplegia following intrathecal chemotherapy.

Authors:  J H Saiki; S Thompson; F Smith; R Atkinson
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

3.  Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.

Authors:  W A Bleyer; J C Drake; B A Chabner
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

4.  Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue.

Authors:  J C Allen; G Rosen; B M Mehta; B Horten
Journal:  Cancer Treat Rep       Date:  1980

5.  [Early neurotoxicity of high-dose of methotrexate and tetrahydrobiopterin deficiency].

Authors:  J C Netter; J L Dhondt; F Rance; M Petrus
Journal:  Arch Fr Pediatr       Date:  1991-12

6.  Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia.

Authors:  K Skullerud; K Halvorsen
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

7.  Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis.

Authors:  B M Mehta; J P Glass; W R Shapiro
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

8.  Transient neurologic disturbances induced by high-dose methotrexate treatment.

Authors:  N Jaffe; Y Takaue; T Anzai; R Robertson
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

9.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

10.  Leukoencephalopathy in childhood leukemia.

Authors:  D C Devivo; D Malas; J S Nelson; V J Land
Journal:  Neurology       Date:  1977-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.